prof. dr. R.A.J.O. (Rudi) Dierckx

Professor

E-mail:
r.a.dierckx umcg.nl

Research

  1. 2010
  2. Eisel, U. L. M., Dobos, N., Dierckx, R., Luiten, P., & Korf, J. (2010). Tumor Necrosis Factor as a Neuroinflammatory Mediator in Alzheimer's Disease and Stroke: Molecular Mechanisms and Neuroinflammatory Imaging. In B. G. Arnason (Ed.), The Brain and Host Defense (9 ed., pp. 251-267). (NeuroImmune Biology; No. 9).
  3. 2009
  4. Fonteyne, P., Casneuf, V., Pauwels, P., Van Damme, N., Peeters, M., Dierckx, R., & Van de Wiele, C. (2009). Expression of hexokinases and glucose transporters in treated and untreated oesophageal adenocarcinoma. Histology and histopathology, 24(8), 971-977.
  5. Bodei, L., Ferone, D., Grana, C. M., Cremonesi, M., Signore, A., Dierckx, R. A., & Paganelli, G. (2009). Peptide receptor therapies in neuroendocrine tumors. Journal of endocrinological investigation, 32(4), 360-369.
  6. Glaudemans, A. W. J. M., Klein, H., de Vries, E. F. J., Doorduin, J., & Dierckx, R. (2009). De rol van nucleaire geneeskunde bij het chronische vermoeidheidssyndroom. In Moei of vermoeid? CVS gewikt en gewogen (pp. 205-219). Standaard Uitgeverij.
  7. Glaudemans, A. W. J. M., Lam, M. G. E. H., Veltman, N. C., Dierckx, R., & Signore, A. (2009). The contribution of nuclear medicine in the diagnosis of bone metastases. In Bone metastases, a translational and clinical approach Springer.
  8. 2008
Previous 1...4 5 6 7 8 9 Next

ID: 255187